Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains +0.56% in November, +7.75% YTD

Monday, December 13, 2010
Opalesque Industry Update - Hedge funds gained 0.56% in November according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 7.75% year-to-date.

“Hedge funds appear to be on their way to another profitable year,” says Sol Waksman, founder and president of BarclayHedge.

"The Barclay Hedge Fund Index has had consistent gains in 13 of the past 14 years. The single losing year was a 23.53% loss in 2008 when global stock markets collapsed."

Fourteen of Barclay’s 18 hedge fund indices were up in November. The Barclay Pacific Rim Index gained 1.80%, Equity Long Bias was up 1.09%, Equity Market Neutral gained 0.92%, and European Equities rose 0.85%.

"With equity markets in all but three developed countries declining in November, equity-based hedge funds certainly earned their fees last month," says Waksman.

The Equity Short Bias Index lost 1.78% in November, Global Macro dropped 0.56%, and Emerging Markets were down 0.23%.

“Although equity prices declined in two-thirds of the developing markets, funds trading in this sector did a good job of limiting losses,” says Waksman. "Potential damage from rising interest rates was also well-contained by managers."

The Barclay Fund of Funds Index gained 0.18% in November, and is up 2.99% for the year.

(press release)

Source

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its